bromodeoxyuridine has been researched along with Eye Cancer, Retinoblastoma in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (37.50) | 18.7374 |
1990's | 1 (12.50) | 18.2507 |
2000's | 4 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kotoula, V; Marks, PA; McMullan, C; Miller, JW; Mitsiades, CS; Mitsiades, N; Negri, J; Poulaki, V | 1 |
Betz, BL; Knudsen, ES; Reisman, DN; Strobeck, MW; Weissman, BE | 1 |
Angus, SP; Knudsen, ES | 1 |
Angus, SP; Betz, BL; Gunawardena, RW; Knudsen, ES; Knudsen, KE; Kowalik, TF; Reisman, DN; Strobeck, MW; Weissman, BE | 1 |
Char, DH; Kaleta-Michaels, S; Kroll, SM; Waldman, FM | 1 |
Bigner, DD; Boyd, JC; Collins, VP; Donoso, LA; Friedman, HS; Herman, MM; Ibayashi, N; Rubinstein, LJ | 1 |
Nakagawa, Y; Perentes, E | 1 |
Koyama, Y; Matsutani, M; Sing, OK; Takakura, K | 1 |
8 other study(ies) available for bromodeoxyuridine and Eye Cancer, Retinoblastoma
Article | Year |
---|---|
Molecular sequelae of histone deacetylase inhibition in human retinoblastoma cell lines: clinical implications.
Topics: Acetylation; Apoptosis; Bromodeoxyuridine; Caspases; Cell Line, Tumor; Cell Proliferation; Cinnamates; Doxorubicin; Drug Synergism; Enzyme Inhibitors; Flow Cytometry; Gene Expression Profiling; Histone Deacetylase Inhibitors; Histones; Humans; Hydroxamic Acids; Immunoblotting; Neoplasm Proteins; NF-kappa B; Retinal Neoplasms; Retinoblastoma; Reverse Transcriptase Polymerase Chain Reaction; Tumor Suppressor Protein p53; Vorinostat | 2009 |
Re-expression of hSNF5/INI1/BAF47 in pediatric tumor cells leads to G1 arrest associated with induction of p16ink4a and activation of RB.
Topics: Bromodeoxyuridine; Cell Cycle; Chromosomal Proteins, Non-Histone; Cyclin A; Cyclin-Dependent Kinase Inhibitor p16; DNA Helicases; DNA-Binding Proteins; Flow Cytometry; G1 Phase; Gene Expression Regulation, Neoplastic; Humans; Hyaluronan Receptors; Infant; Nuclear Proteins; Retinal Neoplasms; Retinoblastoma; Retroviridae; Signal Transduction; SMARCB1 Protein; Transcription Factors; Transfection; Tumor Cells, Cultured; Up-Regulation | 2002 |
Functional analysis of the antimitogenic activity of tumor suppressors.
Topics: Antimetabolites; Bromodeoxyuridine; Cell Cycle; Flow Cytometry; Genes, Tumor Suppressor; Green Fluorescent Proteins; Humans; Indicators and Reagents; Luminescent Proteins; Osteosarcoma; Retinoblastoma; Tumor Cells, Cultured | 2003 |
Compensation of BRG-1 function by Brm: insight into the role of the core SWI-SNF subunits in retinoblastoma tumor suppressor signaling.
Topics: Adenoviridae; Alleles; Antineoplastic Agents; Bromodeoxyuridine; Cisplatin; Cyclin A; DNA Damage; DNA Helicases; DNA-Binding Proteins; Electrophoresis, Polyacrylamide Gel; Humans; Hyaluronan Receptors; Immunoblotting; Mutation; Nuclear Proteins; Phosphorylation; Plasmids; Protein Structure, Tertiary; Retinoblastoma; S Phase; Signal Transduction; Transcription Factors; Transfection; Tumor Cells, Cultured | 2002 |
Retinoblastoma cell cycling.
Topics: Bromodeoxyuridine; Cell Cycle; Child; DNA, Neoplasm; Eye Neoplasms; Flow Cytometry; Humans; Neoplasms, Multiple Primary; Ploidies; Prognosis; Prospective Studies; Retinoblastoma | 1991 |
Relationship of the demonstration of intermediate filament protein to kinetics of three human neuroepithelial tumor cell lines. Lack of neural-related proteins in most cells in S phase: a double-labeled immunohistochemical study on matrix cultures.
Topics: Astrocytoma; Bromodeoxyuridine; Cell Cycle; Humans; Immunoenzyme Techniques; Intermediate Filament Proteins; Interphase; Medulloblastoma; Neurofilament Proteins; Retinoblastoma; Tumor Cells, Cultured; Vimentin | 1989 |
Determination by anti-bromodeoxyuridine monoclonal antibody of cells in S phase in the human Y79 retinoblastoma line maintained in an organ culture system: effects of butyric acid.
Topics: Antibodies, Monoclonal; Bromodeoxyuridine; Butyrates; Butyric Acid; Cell Line; Eye Neoplasms; Humans; Interphase; Organ Culture Techniques; Retinoblastoma | 1987 |
[Treatment of malignant brain tumors by the intrathecal administration of BAR (EUdR-antimetabolite-radiation)].
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antimetabolites; Brain Neoplasms; Bromodeoxyuridine; Carcinoma, Squamous Cell; Child; Child, Preschool; Ependymoma; Female; Glioblastoma; Humans; Injections, Spinal; Male; Medulloblastoma; Meningioma; Methotrexate; Middle Aged; Mitomycins; Pinealoma; Radiation-Sensitizing Agents; Radiotherapy, High-Energy; Retinoblastoma | 1972 |